Suppr超能文献

孕早期肝脏脂肪变性指数作为妊娠期糖尿病的预测指标:中国西北部的一项队列研究

First trimester hepatic steatosis index as a predictor of gestational diabetes mellitus: a cohort study in Northwestern China.

作者信息

Liu Xuhui, Dai Xuegang, Guo Zhiru, Ma Rui, Li Fei, Zhang Ling, Liu Yining, Liang Lixia, He Jian, Wang Yanxia

机构信息

School of Public Health, Gansu University of Chinese Medicine, Lanzhou, 730101, China.

Clinical Trial Facility Office, Gansu Provincial Maternity and Child-Care Hospital, Lanzhou, 730050, China.

出版信息

Sci Rep. 2025 Jul 1;15(1):20975. doi: 10.1038/s41598-025-04510-6.

Abstract

To investigate the predictive value of the hepatic steatosis index (HSI) in the first trimester for gestational diabetes mellitus (GDM), and explore the association between HSI and the risk of developing GDM. A total of 2795 pregnant women were included in this cohort study. Maternal baseline data and basic laboratory data, including alanine aminotransferase, aspartate aminotransferase, fasting plasma glucose (FPG), and others were collected during 8-13 weeks of gestation. The 75-g oral glucose tolerance test was conducted at 24-28 weeks of gestation, and according to the criteria of American Diabetes Association, the participant would be diagnosed as GDM if one of the thresholds was met: fasting blood glucose ≥ 5.1 mmol/L, 1-h blood glucose ≥ 10.0 mmol/L, or 2-h blood glucose ≥ 8.5 mmol/L. The relationship between first-trimester HSI and GDM outcomes was analyzed by using Logistic Regression, Restricted Cubic Spline and Subgroup Analyses. The nomogram model including HSI, FPG and other factors was established, and diagnostic efficacies of the nomogram model, FPG, HSI, and white blood cell count (WBC) were analysed by using the receiver operating characteristic curve. 212 pregnant women were diagnosed with GDM among 2,795.After adjusting for the covariates, compared to women in the lowest quartile (Q1), those in the highest quartile group (Q4) of first-trimester HSI had a 2.328-fold risk of developing GDM (95% CI 1.262-4.295, p < 0.05). There was a positive nonlinear dose-response relationship between the first-trimester HSI and GDM (p for overall < 0.001; p for nonlinear = 0.010). Subgroup analyses found that HSI didn't interact with covariates such as age, gravidity, parity, etc. (p > 0.05). The diagnose efficacies of the nomogram model, HSI, FPG and WBC were 0.737 (95% CI 0.702-0.773), 0.696 (95% CI 0.658-0.734), 0.631 (95% CI 0.593-0.670), and 0.569 (95% CI 0.526-0.611), respectively. First-trimester HSI, FPG, WBC, and age may jointly predict the occurrence of GDM.

摘要

为探讨孕早期肝脂肪变性指数(HSI)对妊娠期糖尿病(GDM)的预测价值,并探究HSI与GDM发生风险之间的关联。本队列研究共纳入2795名孕妇。在妊娠8 - 13周期间收集孕妇的基线数据和基本实验室数据,包括丙氨酸氨基转移酶、天冬氨酸氨基转移酶、空腹血糖(FPG)等。在妊娠24 - 28周进行75克口服葡萄糖耐量试验,根据美国糖尿病协会的标准,若满足以下任何一个阈值,则参与者将被诊断为GDM:空腹血糖≥5.1 mmol/L、1小时血糖≥10.0 mmol/L或2小时血糖≥8.5 mmol/L。采用逻辑回归、限制性立方样条和亚组分析方法分析孕早期HSI与GDM结局之间的关系。建立了包括HSI、FPG和其他因素的列线图模型,并使用受试者工作特征曲线分析列线图模型、FPG、HSI和白细胞计数(WBC)的诊断效能。2795名孕妇中,212名被诊断为GDM。在调整协变量后,与孕早期HSI最低四分位数组(Q1)的女性相比,最高四分位数组(Q4)的女性发生GDM的风险高2.328倍(95%CI 1.262 - 4.295,p < 0.05)。孕早期HSI与GDM之间存在正的非线性剂量反应关系(总体p < 0.001;非线性p = 0.010)。亚组分析发现HSI与年龄、孕周、产次等协变量无相互作用(p > 0.05)。列线图模型、HSI、FPG和WBC的诊断效能分别为0.737(95%CI 0.702 - 0.773)、0.696(95%CI 0.658 - 0.734)、0.631(95%CI 0.593 - 0.670)和0.569(95%CI 0.526 - 0.611)。孕早期HSI、FPG、WBC和年龄可能共同预测GDM的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2f3/12217838/697e8e18433b/41598_2025_4510_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验